FDA Clears Coronary Intravascular Lithotripsy to Breakup Calcified Lesions With Sound Waves
Shockwave Medical s transformative technology now available for calcified coronary plaque
A comparison showing angiography and optical coherence tomography (OCT) views of an undilated mid right coronary artery calcified lesion, post dilation with the Shockwave intravascular lithotripsy system, and the final result after stenting. The technology allows calcified lesions to be broken up without the need for vessel trauma caused by high pressure balloons or atherectomy.
February 17, 2021 The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical s Intravascular Lithotripsy (IVL) system to treat severely calcified coronary artery disease.